Advanced Enzyme Technologies · NSE: ADVENZYMES · BSE: 540025
Q2 FY26 results · Jul–Sep 2025
Advanced Enzyme Technologies reported revenue from operations of ₹184.53 crore (up 26.3% from Q2 FY25) and net profit of ₹44.73 crore (up 34.0% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 184.53 | 146.09 | +26.3% | 185.91 | −0.7% |
| Other income | 10.28 | 9.62 | +6.9% | 8.85 | +16.2% |
| Total income | 194.81 | 155.71 | +25.1% | 194.76 | +0.0% |
| Profit before tax | 59.54 | 42.21 | +41.1% | 54.90 | +8.5% |
| Net profit for the period | 44.73 | 33.39 | +34.0% | 40.44 | +10.6% |
| Attributable to shareholders of the company | 43.33 | 32.83 | +32.0% | 39.93 | +8.5% |
| EPS, basic (₹) | 3.87 | 2.94 | +31.6% | 3.57 | +8.4% |
| Net margin (%) | 24.2 | 22.9 | 21.8 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 115.75 | 77.38 | +49.6% | 125.02 | −7.4% |
| Other income | 3.08 | 1.66 | +86.0% | 53.85 | −94.3% |
| Total income | 118.83 | 79.03 | +50.4% | 178.88 | −33.6% |
| Profit before tax | 29.62 | 12.32 | +140.4% | 81.40 | −63.6% |
| Net profit for the period | 22.28 | 9.13 | +144.2% | 73.98 | −69.9% |
| EPS, basic (₹) | 1.99 | 0.82 | +142.7% | 6.61 | −69.9% |
| Net margin (%) | 19.3 | 11.8 | 59.2 |
Consolidated
- Filed with BSE
- 12 Nov 2025, 14:10 IST
- Board meeting
- 12 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Nov 2025, 14:10 IST
- Board meeting
- 12 Nov 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE